BCR and diffuse large B-cell lymphoma: In activated B cell (ABC) DLBCL cell lines, enhanced BCR signaling and the resultant de novo cholesterol synthesis can significantly reduce the ability of HDL-like nanoparticles (HDL NPs) to reduce cellular cholesterol levels, and induce cell death.